From: Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience
Variables
Number (%)
Response
Complete remission (CR)
38 (92.68%)
Refractory
3 (7.32%)
Relapse
11 (26.83%)
Non-relapse
30 (73.17%)
Survival
Living
31 (75.61%)
Dead
10 (24.39%)